Cystic fibrosis drug improves outcomes in severe COVID-19 pneumonia
Genentech’s Pulmozyme could also treat other respiratory infections and conditions
Read More
Tag: Pulmozyme
- Acoramidis approved for heart condition treatment
- Genomics study launches to optimise childhood cancer care in Ireland
- UCL researchers launch congenital muscular dystrophy research programme
- Novavax shares positive real-world results for JN.1-adapted COVID-19 vaccine
- FDA approves Click’s digital therapeutic for episodic migraine
